Contineum Therapeutics (CTNM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

19.840
-0.240-1.20%

Close Sep 20 16:00 ET

20.330
+0.490+2.47%

Post 20:02 ET

510.35MMarket Cap-25833P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Contineum Therapeutics Is Maintained at Outperform by RBC Capital
Dow JonesAug 14 11:36 ET
Contineum Therapeutics Analyst Ratings
BenzingaAug 14 11:24 ET · Ratings
Morgan Stanley Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Maintains Target Price $25
Moomoo NewsAug 14 09:31 ET · Ratings
RBC Capital Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Raises Target Price to $32
Moomoo NewsAug 14 07:31 ET · Ratings
Express News | Contineum Therapeutics Inc : RBC Raises Target Price to $32 From $30
ReutersAug 14 01:56 ET
Contineum Therapeutics Announces Corporate Presentation Updates
TipRanksAug 13 16:42 ET

Comments

Pinchie McPincher

Apr 19 03:23

$Contineum Therapeutics (CTNM.US)$what am i missing?

Jaguar8

Apr 4 22:56

$Contineum Therapeutics (CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.